ASN Kidney Week abstracts are concise, peer-reviewed summaries of original research presented at the American Society of Nephrology's annual scientific meeting. These submissions cover clinical trials, epidemiological studies, and novel therapeutic approaches in kidney disease, serving as a primary source for emerging findings in nephrology.
Each abstract undergoes review by a committee of experts before acceptance. Authors submit structured reports-typically under 300 words-detailing objectives, methods, results, and conclusions. Accepted abstracts appear in the official program and are published online through the ASN website and journal platforms like Journal of the American Society of Nephrology.
For researchers, clinicians, and students, these abstracts offer early access to data not yet available in full-length journal articles. They also serve as a foundation for future systematic reviews and meta-analyses. The 2023 meeting featured over 1,200 accepted abstracts across 12 thematic tracks, including acute kidney injury, diabetic nephropathy, and transplant immunology.
Abstracts are submitted via the ASN's online portal during a designated window-usually six weeks before the event. Submissions must follow strict formatting guidelines: title, authors, affiliations, background, methods, results, and conclusions. Word counts are enforced, typically capping at 250-300 words.
A multidisciplinary review panel evaluates each submission based on scientific rigor, novelty, and relevance to current nephrology challenges. Acceptance rates hover around 60%, with higher selection thresholds for oral presentations versus poster sessions. Rejected abstracts may be resubmitted the following year with revisions.
Once accepted, abstracts are assigned a unique ID and included in the digital program. Presenters receive a virtual badge and access to live Q&A sessions during the conference. All abstracts are archived and searchable through the ASN's database, which allows filtering by condition, intervention, or geographic region.
The diversity of topics reflects the breadth of modern nephrology. Below is a breakdown of common categories:
| Type | Description | Example Topic |
|---|---|---|
| Clinical trial | Human-based studies testing new drugs or interventions | Effect of sotagliflozin on albuminuria in CKD stage 3b |
| Epidemiological | Population-level data on disease incidence or outcomes | Racial disparities in dialysis initiation among Medicare beneficiaries |
| Basic science | Preclinical models exploring molecular mechanisms | Role of mitochondrial dysfunction in podocyte apoptosis |
| Transplantation | Studies on graft survival, rejection, or donor allocation | Impact of donor-specific antibodies on long-term allograft function |
Abstracts involving artificial intelligence in imaging analysis have increased by 42% since 2020, according to ASN's 2023 program report. This trend highlights growing integration of machine learning tools in diagnosing glomerular diseases from renal biopsy images.
Many assume that all abstracts are published in peer-reviewed journals. That is incorrect. While some abstracts are later expanded into full manuscripts, most remain accessible only through the ASN's conference platform unless separately submitted to journals.
Another misconception is that abstracts represent finalized results. In reality, many are preliminary findings. For example, the 2022 abstract "Preliminary efficacy of sparsentan in focal segmental glomerulosclerosis" reported early phase II data with confidence intervals spanning 1.5 to 3.2. Final results were confirmed in a 2023 publication in JASN.
Also, abstracts are not always representative of larger trials. A 2021 study in NEJM Evidence found that 38% of abstracts reporting positive outcomes in small cohorts failed replication in subsequent randomized controlled trials. This underscores the need to treat abstracts as hypotheses, not conclusions.
In 2023, an abstract titled "Long-term outcomes of home hemodialysis in rural populations" was presented by a team from the University of Iowa. The study analyzed 18 months of data from 47 patients across five Midwestern counties. Key findings included a 29% reduction in hospitalizations and a 22% improvement in patient-reported quality of life compared to center-based dialysis.
These results informed a pilot grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which awarded $1.2 million to expand home dialysis programs in underserved areas. The abstract itself did not contain the full statistical model, but it provided enough detail to justify further funding.
Later, the same group published a full paper in Journal of the American Society of Nephrology, citing the abstract as the initial evidence base. This illustrates how abstracts act as catalysts-providing early signals that lead to larger investments and policy changes.
I attended the 2022 ASN Kidney Week session on metabolic acidosis in CKD. One abstract stood out: a multicenter trial showing that bicarbonate supplementation reduced progression to end-stage renal disease by 34% over three years. The presenter, Dr. Elena Torres, used only two slides and focused on the hazard ratio (HR = 0.66, 95% CI 0.51-0.85).
Her delivery emphasized clarity over complexity. After the talk, several attendees approached her with requests for raw data. The abstract had sparked interest not because of flashy visuals, but because it answered a high-priority clinical question with measurable impact.
Access is free through the official ASN Kidney Week website. Search by keyword, author, or track. Filters allow sorting by presentation format (oral, poster, virtual), date, or condition. Abstracts are also indexed in PubMed and Google Scholar.
Researchers use them to identify gaps in literature, inform grant proposals, and benchmark their own work. Clinicians reference them to stay updated on guideline-relevant data. Students learn how to structure scientific communication and evaluate methodological soundness.
For example, a 2023 abstract on wearable sensors for monitoring fluid status in heart failure patients with CKD was cited in a NIH-funded project proposal on remote monitoring systems. The abstract's inclusion of validation metrics-sensitivity 89%, specificity 84%-provided critical evidence for feasibility.
While not all abstracts reach broad audiences, those with strong methodology and clear implications often influence both practice and policy. The 2021 abstract "Cost-effectiveness of early referral to nephrology care" led to revised CMS reimbursement models for pre-dialysis education services.
asn kidney week abstracts are essential gateways to modern nephrology research. They provide timely insights into evolving treatments, diagnostic tools, and public health strategies. Their structured format ensures consistency, while their peer-review process maintains scientific integrity.
Use them to track innovation, validate hypotheses, or identify collaborators. Always assess context-preliminary findings require cautious interpretation. But when read critically, these documents deliver useful evidence for advancing kidney health worldwide.